<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">Metastatic colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells have a selective preference for certain target organs that cannot be explained by circulatory patterns alone </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to identify clinicopathological features and chromosomal aberrations of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumours</z:e> associated with organ-specific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Clinicopathological features were investigated in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> who had exclusively hepatic (n=182) versus exclusively extrahepatic (n=139) <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 139 primary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> of patients with hepatic (n=85) and extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (n=54) were screened for chromosomal aberrations by microarray-based comparative genomic hybridisation, and the findings were validated in an independent set of 80 primary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A publicly available database was used to correlate chromosomal aberrations with gene expression </plain></SENT>
<SENT sid="5" pm="."><plain>Protein expression was evaluated by immunohistochemistry on tissue microarrays </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> were significantly more often male (71% vs 53% p=0.002), more often had abnormal <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase activity (37% vs 14% p&lt;0.0001), exhibited <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> localisation in the colon (52% vs 40% p=0.03) and had synchronous <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (70% vs 19% p&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">Primary tumours</z:e> of patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> were more commonly T3 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (79% vs 63% p=0.006) and less commonly of mucinous histology (5% vs 16% p=0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>Gain of 20p11 was more often observed in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> (p&lt;0.05), which was confirmed in an independent dataset (p&lt;0.05; false discovery rate &lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Twelve genes mapping at 20p11 were significantly overexpressed as a consequence of 20p11 copy number gain </plain></SENT>
<SENT sid="10" pm="."><plain>C20orf3 showed the strongest correlation between <z:chebi fb="40" ids="33697">RNA</z:chebi> expression and DNA copy number </plain></SENT>
<SENT sid="11" pm="."><plain>This was reflected in significantly higher protein expression in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> (59%; n=325) than in those with extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (41%; n=256) (p=0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: C20orf3 mapping at 20p11 is associated with hepatic-specific <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>This gene is a candidate biomarker for <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and may be of clinical value in early-stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>